Drug recall · June 9, 2021
Thiamine HCl Injection recall
Why: Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Thiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL vials, packaged in 25 (2 mL multi-dose vial) per carton, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA; Manufactured by: Mylan Institutional, Galway, Ireland. NDC: 67457-196-02
- Lots / codes
Lot #: 200906, Exp. Date February 2022
- Quantity
- 2,131 cartons
- Company
- Mylan Institutional LLC, Rockford, IL
- Distribution
- Nationwide within the United States
- Initiated
- May 3, 2021 · Voluntary: Firm initiated
- Classified
- June 1, 2021
- Reported
- June 9, 2021
- Ended
- October 18, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Thiamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.